Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding
Others
Ratios

Syndax Pharmaceuticals (SNDX) Other Non Operating Income (2016 - 2017)

Historic Other Non Operating Income for Syndax Pharmaceuticals (SNDX) over the last 3 years, with Q4 2017 value amounting to -$76000.0.

  • Syndax Pharmaceuticals' Other Non Operating Income fell 23103.45% to -$76000.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$269000.0, marking a year-over-year decrease of 75609.76%. This contributed to the annual value of -$247000.0 for FY2024, which is 3157.89% up from last year.
  • As of Q4 2017, Syndax Pharmaceuticals' Other Non Operating Income stood at -$76000.0, which was down 23103.45% from -$53000.0 recorded in Q3 2017.
  • Syndax Pharmaceuticals' Other Non Operating Income's 5-year high stood at $58000.0 during Q4 2016, with a 5-year trough of -$87000.0 in Q2 2017.
  • Over the past 3 years, Syndax Pharmaceuticals' median Other Non Operating Income value was -$27500.0 (recorded in 2015), while the average stood at -$25900.0.
  • As far as peak fluctuations go, Syndax Pharmaceuticals' Other Non Operating Income soared by 48000.0% in 2016, and later tumbled by 540000.0% in 2017.
  • Quarter analysis of 3 years shows Syndax Pharmaceuticals' Other Non Operating Income stood at $10000.0 in 2015, then surged by 480.0% to $58000.0 in 2016, then tumbled by 231.03% to -$76000.0 in 2017.
  • Its Other Non Operating Income stands at -$76000.0 for Q4 2017, versus -$53000.0 for Q3 2017 and -$87000.0 for Q2 2017.